GlassScriptPhysician profile
Peter Fredrick Crossno
NPI 1083761936
$16,051.86
in general payments reported to CMS, 2019-2025
7 companies · $8,832 in 2025
The $8,832 reported for 2025 was more than what 94% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,296 · 2022: $181 · 2023: $2,605 · 2024: $138 · 2025: $8,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,950 · Travel and Lodging: $2,675 · Food and Beverage: $1,911 · Education: $39.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,950.00 |
| Travel and Lodging | $2,674.73 |
| Food and Beverage | $1,910.89 |
| Education | $39.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $11,634.78 | 2021-2025 | Tyvaso, Tyvaso, Remodulin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,143.29 | 2021-2023 | Ofev |
| Astrazeneca Pharmaceuticals LP | $77.92 | 2024 | |
| Jazz Pharmaceuticals INC. | $58.50 | 2023 | |
| Verona Pharma, INC. | $49.66 | 2025 | Ohtuvayre |
| Baxter Healthcare | $48.09 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $39.62 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Crossno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.